Bio-Techne
TECH
#1576
Rank
ยฃ8.50 B
Marketcap
ยฃ53.54
Share price
-6.85%
Change (1 day)
9.15%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): ยฃ0.92 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is ยฃ0.91 Billion. In 2023 the company made a revenue of ยฃ0.89 Billion a decrease over the revenue in the year 2022 that were of ยฃ0.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.92 B2.73%
2023 ยฃ0.89 B-2.91%
2022 ยฃ0.92 B21.36%
2021 ยฃ0.76 B30.13%
2020 ยฃ0.58 B3.21%
2019 ยฃ0.56 B5.75%
2018 ยฃ0.53 B21.1%
2017 ยฃ0.44 B3.62%
2016 ยฃ0.42 B36.37%
2015 ยฃ0.31 B19.62%
2014 ยฃ0.26 B31.09%
2013 ยฃ0.20 B3.55%
2012 ยฃ0.19 B-2%
2011 ยฃ0.19 B11.68%
2010 ยฃ0.17 B7.93%
2009 ยฃ0.16 B-10.67%
2008 ยฃ0.18 B52.43%
2007 ยฃ0.12 B11.18%
2006 ยฃ0.10 B-2.52%
2005 ยฃ0.11 B26.59%
2004 ยฃ87.59 M2.13%
2003 ยฃ85.76 M-0.18%
2002 ยฃ85.92 M2.18%
2001 ยฃ84.09 M15.68%
2000 ยฃ72.69 M20.08%
1999 ยฃ60.53 M27.26%
1998 ยฃ47.57 M23.06%
1997 ยฃ38.65 M14.71%
1996 ยฃ33.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ33.55 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.04 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.71 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.87 B 1,628.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.53 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ43.11 B 4,594.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.28 M-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA